Open Nav

Please submit your session questions in advance at

New Treatments for Diabetes and Obesity: Innovations for Chronic Diseases

BIO’s latest report on highly prevalent chronic diseases shows a slowdown in overall investment for new treatments for diabetes and obesity (available at However, there remain signs of hope in the early-stage pipeline. This session will detail the drug pipeline, which research approaches are convincing skeptical investors, as well as opportunities for overcoming high-cost clinical trials and reimbursement barriers.

Moderator: Jason Butler, PhD, Managing Director and Senior Analyst, JMP Securities

  • Date:Tuesday, February 12
  • Time:9:00 AM - 9:55 AM
  • Room:Shubert Complex
  • Location:6th Floor
  • Session Type:Educational Panel
  • Please submit your session questions in advance:

    Click here.

Jason Butler
JMP Securities
Vered Caplan
Steve Daly
Dara Schuster
T1D Exchange
David Thomas
Biotechnology Innovation Organization (BIO)